A Study To Assess The Duration Of Action Of PF-03526299 In Asthmatic Subjects Following Allergen Challenge

NCT01299467 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Active (PF-03526299)
DRUG: Active (PF-03526299)
DRUG: Placebo
DRUG: Active (PF-03526299)
DRUG: Active (PF-03526299)
DRUG: Placebo

Sponsor

Pfizer